查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009189

感染疾病監測解決方案市場規模、佔有率、趨勢和預測：按組件、部署類型、最終用戶和地區分類，2026-2034 年

Infection Surveillance Solutions Market Size, Share, Trends and Forecast by Component, Deployment Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年全球感染監測解決方案市場規模達7.536億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到14.083億美元，2026年至2034年的複合年成長率為6.98%。市場成長的主要促進因素包括醫療相關感染（HAI）的增加、為防止感染傳播而採取的更嚴格的監管措施，以及醫療IT技術的進步，使得自動化患者資料收整合為可能。

感染監測解決方案是由醫療機構實施的綜合系統，用於監測和分析其患者群體中感染疾病的流行、傳播途徑和影響。這些解決方案利用先進的數據收集、整合和分析工具，追蹤和報告各種醫療相關感染疾病（HAI），包括血流感染疾病、手術部位感染疾病和呼吸道感染疾病。隨著感染疾病監測解決方案能夠幫助醫護人員快速識別潛在疫情、實施針對性應對措施並最終提升病患安全，全球對這類解決方案的需求正在不斷成長。

目前，人們對病患安全（包括感染控制）的日益關注正在推動市場成長。此外，人們越來越認知到數據驅動決策在醫療保健領域的重要性，這也促進了市場成長。同時，老年人群對感染疾病監測解決方案的需求不斷成長，也對市場產生了正面影響。此外，對用於監測和控制感染疾病爆發的監測解決方案的投資增加，也為產業投資者帶來了極具吸引力的成長機會。此外，數據分析、人工智慧 (AI) 和機器學習 (ML) 領域的創新正在提升感染疾病監測解決方案的能力和效率，進一步支持市場成長。最後，全球醫療保健基礎設施的建設也在推動市場成長。

感染疾病監測解決方案市場的趨勢與促進因素：

醫療相關感染疾病（HAI）增加

醫療相關感染疾病（HAI）在人群中的日益普遍，推動了感染疾病監測解決方案的普及，從而促進了市場成長。這些感染疾病威脅患者健康，導致住院時間延長、醫療成本增加，甚至在某些情況下導致死亡。同時，人們也越來越需要採取措施來降低這些感染疾病，進而提高病人安全。透過持續監測和分析患者數據，這些解決方案能夠及早發現感染疾病，使醫療機構能夠及時採取行動。因此，降低HAI的發生率不僅能改善病患預後，還能為醫療機構節省成本。

嚴格遵守相關規定以防止感染傳播

在醫療產業，遵守監管要求和認證標準至關重要。醫療保險和醫療補助服務中心 (CMS) 和聯合委員會等監管機構強制要求報告和預防醫療相關感染 (HAI)。此外，不遵守規定可能導致罰款和聲譽損害。感染監測解決方案在確保合規方面發揮關鍵作用。它們有助於準確收集、分析和報告感染率，幫助醫療機構有效率地滿足監管要求。此外，認證機構也強調感染控制是醫療品質的關鍵要素。醫療機構也在投資先進的感染監測系統，這些系統不僅滿足監管要求，還有助於獲得和維持認證，從而提升其聲譽和信譽。

醫療資訊科技的進步

電子健康記錄(EHR)、交換醫療資訊(HIE) 和整合醫療保健系統的日益普及正在推動市場成長。因此，感染監測解決方案能夠與現有的醫療保健IT基礎設施無縫整合，實現患者數據、檢測結果和其他相關資訊的自動採集。這種整合簡化了監測流程，並提供即時數據分析，從而創造了良好的市場前景。醫療保健專業人員可以快速獲得可操作的洞察，有助於及早發現和應對潛在的疫情爆發。此外，這些解決方案和醫療保健 IT 不僅能夠加強感染控制，還有助於提高醫療保健服務的整體效率和效果。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球感染疾病監測解決方案市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依組件分類

  • 軟體
  • 服務

第7章 市場區隔：依部署類型分類

  • 現場
  • 基於雲端的

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 門診部
  • 專業醫療中心
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Baxter International Inc.
    • Becton, Dickinson And Company
    • Biomerieux
    • Clinisys, Inc.
    • Inovalon
    • Medexter Healthcare
    • Pointclickcare
    • Premier, Inc.
    • RLDatix
    • Vecna Technologies
    • Vizzia Technologies（HID Global Corporation）
    • Wolters Kluwer NV
Product Code: SR112026A4857

The global infection surveillance solutions market size reached USD 753.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,408.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.98% during 2026-2034. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

Breakup by Component:

  • Software
  • Services

Software represents the largest market segment

Breakup by Deployment Type:

  • On-premises
  • Cloud-based

On-premises accounts for the majority of the market share

Breakup by End User:

  • Hospitals
  • Clinics
  • Ambulatory Service Centers
  • Specialty Centers
  • Others

Hospitals hold the biggest market share

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Baxter International Inc.
  • Becton, Dickinson And Company
  • Biomerieux
  • Clinisys, Inc.
  • Inovalon
  • Medexter Healthcare
  • Pointclickcare
  • Premier, Inc.
  • RLDatix
  • Vecna Technologies
  • Vizzia Technologies (HID Global Corporation)
  • Wolters Kluwer N.V.

Key Questions Answered in This Report

  • 1.What was the size of the global infection surveillance solutions market in 2025?
  • 2.What is the expected growth rate of the global infection surveillance solutions market during 2026-2034?
  • 3.What are the key factors driving the global infection surveillance solutions market?
  • 4.What has been the impact of COVID-19 on the global infection surveillance solutions market?
  • 5.What is the breakup of the global infection surveillance solutions market based on the component?
  • 6.What is the breakup of the global infection surveillance solutions market based on the deployment type?
  • 7.What is the breakup of the global infection surveillance solutions market based on the end user?
  • 8.What are the key regions in the global infection surveillance solutions market?
  • 9.Who are the key players/companies in the global infection surveillance solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Surveillance Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Service Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Specialty Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton, Dickinson And Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biomerieux
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Clinisys, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Inovalon
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medexter Healthcare
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Pointclickcare
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Premier, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 RLDatix
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vecna Technologies
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vizzia Technologies (HID Global Corporation)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Wolters Kluwer N.V.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2025
  • Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2025
  • Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2025
  • Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
  • Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
  • Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million USD), 2026-2034
  • Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million USD), 2026-2034
  • Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
  • Table 7: Global: Infection Surveillance Solutions Market: Key Players